PE Firm · Capital Allocator

Vivo Capital

Medium
Headquarters not yet mapped · Website
Last verified
10/10/2026

Firm Overview

94
Portfolio tracked
0
Sectors
0
Regions
10/10/2026
Last verified

Health-care focused investment firm.

Leadership

Frank Kung
Co-Founder and Managing Partner
Dr. Engelhardt is a Co-Founder and Managing Partner of Vivo Capital.
Edgar Engleman
Co-Founder and Managing Partner
Dr. Engleman is a Co-Founder and Managing Partner of Vivo Capital and a Professor of Pathology and Medicine at Stanford University School of Medicine.
Shan Fu
Managing Partner and CEO
Mr. Fu is a Managing Partner and CEO of Vivo Capital.
Jack B. Widder
Managing Partner
Mr. Widder is a Managing Partner of Vivo Capital.
Hongbo Cao
Managing Partner
Mr. Cao is a Managing Partner of Vivo Capital.
Kevin Chen
Managing Partner
Dr. Chen is a Managing Partner of Vivo Capital.
Gaurav Aggarwal
Managing Partner
Dr. Ma is a Managing Partner of Vivo Capital.
Michael Lee
Managing Director
Mr. Lee is a Managing Director of Vivo Capital.
David Zhao
Managing Director
Dr. Zhao is a Managing Director of Vivo Capital.
Grace Xu
Managing Director
Dr. Xu is a Managing Director of Vivo Capital.
Luke Yin
Managing Director
Dr. Yin is a Managing Director of Vivo Capital.
Stephan Law
Managing Director and CFO
Mr. Law is a Managing Director and Chief Financial Officer of Vivo Capital.
Trency Qin
Managing Director
Mr. Qin is a Managing Director of Vivo Capital.
Yining (Ethan) Tang
Managing Director
Dr. Tang is a Managing Director of Vivo Capital.
Ben Song
Managing Director
Mr. Song is a Managing Director of Vivo Capital.

Portfolio Companies

CompanySectorStatusWebsite
Aadi Bioscience—CurrentVisit ↗
Ablaze Pharmaceuticals—Current—
Achieve Life Sciences—CurrentVisit ↗
ADARx Phamaceuticals—CurrentVisit ↗
Adaxion Therapeutics—CurrentVisit ↗
Aerobiotix—CurrentVisit ↗
Agno Pharma—CurrentVisit ↗
Ajax Therapeutics Inc.—CurrentVisit ↗
AkiraBio—CurrentVisit ↗
Alto Neuroscience—CurrentVisit ↗
Ascendis Pharma—CurrentVisit ↗
Aslan Pharmaceuticals—Current—
Avadel Pharmaceuticals—CurrentVisit ↗
Avistone Pharmaceuticals—CurrentVisit ↗
BioDlink—CurrentVisit ↗
Bisirna Therapeutics—Current—
BlossomHill Therapeutics—CurrentVisit ↗
Bolt Biotherapeutics—CurrentVisit ↗
Bonraybio—CurrentVisit ↗
Bonum Therapeutics—CurrentVisit ↗
Caidya—CurrentVisit ↗
Cidara Therapeutics—CurrentVisit ↗
Clasp Therapeutics—CurrentVisit ↗
Compass Pathways—CurrentVisit ↗
Compass Therapeutics—CurrentVisit ↗
Createrna Science and Technology—CurrentVisit ↗
Dominique Dutscher—CurrentVisit ↗
Epibiologics—CurrentVisit ↗
Esco Aster—CurrentVisit ↗
Esco Lifesciences Group—CurrentVisit ↗
Evaheart Medical Device—CurrentVisit ↗
Fortis Therapeutics—CurrentVisit ↗
Genetron—CurrentVisit ↗
HanchorBio—CurrentVisit ↗
HCMed Innovations—CurrentVisit ↗
Histowiz—CurrentVisit ↗
Immune-Onc Therapeutics—CurrentVisit ↗
ImmunEdge—Current—
Inspirna—CurrentVisit ↗
Instil Bio—CurrentVisit ↗
IO Biotech—CurrentVisit ↗
IVERIC Bio—CurrentVisit ↗
Kinaset Therapeutics—CurrentVisit ↗
Kira Pharmaceuticals—CurrentVisit ↗
Lepu Biopharm—CurrentVisit ↗
Lepu Scientech Medical Technology—CurrentVisit ↗
Maculogix—Current—
Magnolia Medical Technologies—CurrentVisit ↗
Mereo BioPharma Group—CurrentVisit ↗
Metacrine—CurrentVisit ↗
Minerva Neurosciences—CurrentVisit ↗
Neocis—CurrentVisit ↗
Neurogastrx—CurrentVisit ↗
New Frontier Corporation—CurrentVisit ↗
Oricell Therapeutics—CurrentVisit ↗
Ossium Health—CurrentVisit ↗
Outrigger Therapeutics—Current—
Pasithea Therapeutics—CurrentVisit ↗
Precision BioSciences—CurrentVisit ↗
Provivi—CurrentVisit ↗
Pulmocide—CurrentVisit ↗
RareStone Group—CurrentVisit ↗
Rayzebio—CurrentVisit ↗
RemeGen—CurrentVisit ↗
Rgenta Therapeutics—CurrentVisit ↗
RiboX Therapeutics—CurrentVisit ↗
Ronovo Surgical—CurrentVisit ↗
Sanegene Bio—CurrentVisit ↗
Satsuma Pharmaceuticals—CurrentVisit ↗
Scientia Vascular—CurrentVisit ↗
Sera Prognostics—CurrentVisit ↗
Seran Bioscience—CurrentVisit ↗
Serapha Bio—CurrentVisit ↗
Sierra Oncology—CurrentVisit ↗
Silence Therapeutics—CurrentVisit ↗
Sinovac Biotech—CurrentVisit ↗
Sinovac Life & Sciences—CurrentVisit ↗
SonoThera—CurrentVisit ↗
Suzhou Omini Pharmaeutical—CurrentVisit ↗
Tarsus Pharmaceuticals—CurrentVisit ↗
Tebra Technologies—CurrentVisit ↗
Tenax Therapeutics—CurrentVisit ↗
Terns Pharmaceuticals—CurrentVisit ↗
Theranica Bio-Electronics—CurrentVisit ↗
Tourmaline Bio—CurrentVisit ↗
Tranquis Therapeutics—CurrentVisit ↗
Vellum Biotechnology—Current—
Verona Pharma—CurrentVisit ↗
Visen Pharmaceuticals—CurrentVisit ↗
Visirna Therapeutics—CurrentVisit ↗
Wanmei Interactive—Current—
WuXi PharmaTech—CurrentVisit ↗
Zai Lab—CurrentVisit ↗
Zenas Biopharma—CurrentVisit ↗

Source: https://vivocapital.com/portfolio

Portfolio Web Readiness

Not yet assessed

The assessment covers whether AI crawlers and search engines can reach and parse the public site, page performance, transport and security hygiene, and discoverability. 86 portfolio companies have a website on record.

Observational measurements of these companies' public websites only. Not a rating of the companies, their performance, their management, or their investment merit. Not investment advice. Request a correction or removal via Submit Update.

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Vivo Capital and does not provide investment advice.

More PE firms

Browse the full PE firms directory.